The two pumps commonly found to confer chemoresistance in cancer are P-glycoprotein and the so-called multidrug resistance–associated protein (MRP). Because of their function and importance ...
Investigators at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID) have generated an hMPV fusion glycoprotein (“F protein”) stabilized in a ...
Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...
Tocilizumab and rituximab reduce relapse rates and disability progression in NMOSD, with tocilizumab provides extra benefits in MOGAD.
After his initial postdoctoral training in the Donehower/Butel scientific boot camp at Baylor, Don moved to Texas A&M University in 1987 to begin studying glycoprotein biosynthesis and processing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results